ContextThroughout the past 40 years, a vast and sometimes contradictory literature has
accumulated regarding hypertrophic cardiomyopathy (HCM), a genetic cardiac disease …

recommendations. A new section on the use of intraoperative transesophageal
echocardiography (TEE) is being added to update the guidelines published by the American …

The rationale for offering an expert consensus document concerning the participation in
competitive sports by individuals with cardiovascular (CV) disease is based on the widely …

The members of the Task Force on Sudden Death dedicate this paper to the memory of our
former friend and colleague, Professor Ronald WF Campbell. Ronnie spent his life working …

Background—Death resulting from hypertrophic cardiomyopathy (HCM), particularly when
sudden, has been reported to be largely confined to young persons. These data emanated …

Writing Committee consisted of acknowledged experts in hypertrophic cardiomyopathy
(HCM) representing the American College of Cardiology Foundation and the European …

Background Hypertrophic cardiomyopathy is a genetic disease associated with a risk of
ventricular tachyarrhythmias and sudden death, especially in young patients. Methods We …

It is well known that cardiovascular diseases have a substantial heritable component, but the
precise genetic variants responsible for this familial tendency have been hard to uncover. In …

ContextHypertrophic cardiomyopathy (HCM) has been regarded as a disease that causes
substantial disability, with annual mortality rates of up to 6%, based largely on reports from …

A group of relatively uncommon but important genetic cardiovascular diseases (GCVDs) are
associated with increased risk for sudden cardiac death during exercise, including …